Glaukos Corp. (NYSE:GKOS) shares jumped 17.61% to $213.38 in after-hours trading Wednesday after the eye-care company beat third-quarter earnings per share estimates by 570% and raised its sales guidance.

The company reported results for the quarter ended Sept. 30.

Earnings and Revenue Beat

Revenue came in at $211.03 million, topping the analyst estimate of $168.22 million by 25.4%.

Non-GAAP earnings per share were $0.47, compared with an expected loss of 10 cents. That is a 570% surprise.

Net sales rose 58% year over year to $133.5 million.

Gross margin was about 85%, up from 78% a year earlier. Non-GAAP gross margin was about 88%.

Guidance Raise Drives the Rally

The company lifted 2026 net sales guidance to $775 million to $785 million, up from $680 million to $700 million.

Chairman and CEO Thomas Burns credited "two transformational growth drivers in iDose TR and Epioxa."

Glaukos ended the quarter with $339.8 million in cash.

Trading Metrics, Technical Analysis

Glaukos has a market capitalization of $10.70 billion, a 52-week high of $191.62 and a 52-week low of $76.88.

The Relative Strength Index (RSI) of GKOS stands at 64.76.

The stock has gained roughly 135.35% over the past 12 months.

Price Action: On Wednesday, GKOS stock closed at $181.43, up 0.14%, according to Benzinga Pro data.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo: Jirapong Manustrong / Shutterstock – ejk

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.